Effect of Ozurdex® 0.7 mg on Improvement of Efficacy of Bevacizumab for Central Retinal Vein Occlusion
Completed · Phase 2/Phase 3 · Has a placebo group
Conditions studied: Non-Ischemic Central Retinal Vein Occlusion
In brief
This is a study designed to determine if the addition of Ozurdex® to bevacizumab (Avastin®) eye injections reduces the need for repeat bevacizumab eye injections in patients with nonischemic central retina vein occlusion.
Key facts
- Study ID
- NCT01295112
- Run by
- Texas Retina Associates
- People needed
- 68
- Starts
- 2011-05-01
- Expected to finish
- 2015-10-01
- Last updated by the study team
- 2025-09-25
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- male or female subjects (aged 18 or older);
- provide written informed consent and sign/date a health information release;
- women of childbearing potential must be willing to practice effective contraception for the duration of the study.
You may not qualify if…
- any systemic disease or clinical evidence of any condition which would make the subject, in the opinion of the investigator, unsuitable for the study or could potentially confound the study results;
- use of systemic steroids within 1 month prior to Baseline Visit (Visit 1) or anticipated use at any time during the study (inhaled and intranasal steroids are allowed);
- sitting systolic blood pressure equal to or greater than 160 mmHg or diastolic blood pressure equal to or greater than 100 mmHg at the Baseline Visit (Visit 1);
- use of warfarin, heparin, enoxaparin or similar anticoagulants within 2 weeks prior to Baseline Visit (Visit 1) or anticipated use at any time during the study;
- known allergy or hypersensitivity to the study medications or their components;
- previous enrollment in an Ozurdex® clinical trial or previous use of an Ozurdex® implant.
Where it is running
- Texas Retina Associates — Dallas, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.